MaxCyte, NIH NIAID Study Published in Science Translational Medicine Demonstrates CRISPR-Cas9 Repair of X … – PR Newswire (press release)
|
MaxCyte, NIH NIAID Study Published in Science Translational Medicine Demonstrates CRISPR-Cas9 Repair of X …
PR Newswire (press release) The study was published in Science Translational Medicinei and entitled "CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease." Using MaxCyte's patented Flow Electroporation™ Technology, … |
